GamingWithKev recreates the addictive Slither.io experience inside Happy Wheels with wild and unexpected results. Trump turns 80 with a showstopping spectacle of cage fights at the White House. But ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Mayim Bialik is sharing her "nightmare" experience on a GLP-1 medication. In a piece published in The Free Press on June 5, titled "Mayim Bialik: My GLP-1 Nightmare," the "Big Bang Theory" star and ...

Correspondent. "CBS News Sunday Morning" and "48 Hours" Tracy Smith is an award-winning correspondent for "CBS News Sunday Morning" and "48 Hours," who joined CBS News in 2000. Smith has covered a ...

The obesity and diabetes markets are on the cusp of transformation, driven by cutting-edge GLP-1 therapies. Eli Lilly and Novo Nordisk are shaping the competitive landscape, with novel drugs like ...

Mayim Bialik says she experienced severe side effects after taking one GLP-1 injection at the recommendation of her doctor. "For the first two days, I ate maybe one cup of rice and half a banana," she ...

(NEXSTAR) – GLP-1 drugs, which have grown incredibly popular in recent years for their ability to help people lose substantial weight, are now friendlier to needle-phobes. The class of medications, ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science - and culture - of weight loss. Now a growing body of research is raising ...

The enormous popularity of new weight-loss drugs often eclipses the downsides: the burden of weekly injections, rough gastrointestinal side effects, muscle and bone loss. That is shaping a race among ...

Samantha had enjoyed her weekend cooking ritual for years. Four months into Zepbound (a popular GLP-1 medicine), however, something changed. She stood in her kitchen on a Saturday morning and made the ...

Bialik detailed her experience with a weight-loss drug in a personal essay, saying the reaction left her needing IV fluids and unable to keep food down Angelique Brenes is a writer-reporter at PEOPLE.